soul trial oral semaglutide cardiovascular outcomes 2025 results nejm 2024 🔴 Cardiovascular with by severity of chronic kidney disease in type 2 diabetes: the soul trial oral semaglutide cardiovascular – soul trial oral semaglutide cardiovascular

Preventive Health Optimization From a functional medicine perspective, early intervention with low-dose GLP-1s may help prevent the cascade of chronic conditions that stem from metabolic dysfunction

In the GLP-1 Drug Market, the Indication segment is primarily driven by Type 2 Diabetes, which holds the largest market share at 52% due to its high prevalence and increasing awareness of chronic disease management

Common side effects include nausea, vomiting, headaches, gas, and diarrhea

Along with sodium, Himalayan pink salt also contains trace amounts of minerals like magnesium, potassium, and calcium, all of which are necessary for your body to function properly

Figure 2 3